{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T09:38:46Z","timestamp":1787564326265,"version":"build-2736575974"},"reference-count":27,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,19]],"date-time":"2024-01-19T00:00:00Z","timestamp":1705622400000},"content-version":"vor","delay-in-days":3001,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["23591423"],"award-info":[{"award-number":["23591423"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","exphem.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.exphem.2015.07.006","type":"journal-article","created":{"date-parts":[[2015,8,15]],"date-time":"2015-08-15T14:01:51Z","timestamp":1439647311000},"page":"921-929.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome"],"prefix":"10.1016","volume":"43","author":[{"given":"Hirohisa","family":"Nakamae","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takako","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Nishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Nakane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Nakamae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asao","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.07.006_bib1","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.bbmt.2008.03.005","article-title":"HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide","volume":"14","author":"Luznik","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib2","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1053\/bbmt.2002.v8.pm12171484","article-title":"Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide","volume":"8","author":"O'Donnell","year":"2002","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1097\/MOH.0b013e32833eaf1b","article-title":"High-dose cyclophosphamide for graft-versus-host disease prevention","volume":"17","author":"Luznik","year":"2010","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.exphem.2015.07.006_bib4","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1053\/j.seminoncol.2012.09.005","article-title":"Post-transplantation cyclophosphamide for tolerance induction in HLA-haploidentical bone marrow transplantation","volume":"39","author":"Luznik","year":"2012","journal-title":"Semin Oncol"},{"key":"10.1016\/j.exphem.2015.07.006_bib5","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1182\/blood-2011-03-344853","volume":"118","author":"Brunstein","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.07.006_bib6","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.3109\/10428194.2011.647017","article-title":"Different immunoprofiles in patients with chronic myeloid leukemia treated with imatinib, nilotinib or dasatinib","volume":"53","author":"Hayashi","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.exphem.2015.07.006_bib7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12185-011-0805-z","article-title":"Reduced-intensity conditioning by fludarabine\/busulfan without additional irradiation or T-cell depletion leads to low nonrelapse mortality in unrelated bone marrow transplantation","volume":"93","author":"Nakane","year":"2011","journal-title":"Int J Hematol"},{"key":"10.1016\/j.exphem.2015.07.006_bib8","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ijid.2013.09.020","article-title":"Prophylactic role of long-term ultra-low-dose acyclovir for varicella zoster virus disease after allogeneic hematopoietic stem cell transplantation","volume":"19","author":"Kawamura","year":"2014","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.exphem.2015.07.006_bib9","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1016\/j.transproceed.2011.08.104","article-title":"Immunoglobulin prophylaxis against cytomegalovirus infection in patients at high risk of infection following allogeneic hematopoietic cell transplantation","volume":"43","author":"Ichihara","year":"2011","journal-title":"Transplant Proc"},{"key":"10.1016\/j.exphem.2015.07.006_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib11","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s15010-014-0657-6","article-title":"Diagnostic performance of serum high-sensitivity procalcitonin and serum C-reactive protein tests for detecting bacterial infection in febrile neutropenia","volume":"42","author":"Aimoto","year":"2014","journal-title":"Infection"},{"key":"10.1016\/j.exphem.2015.07.006_bib12","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1016\/j.bbmt.2012.06.019","volume":"18","author":"Solomon","year":"2012","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.bbmt.2008.12.503","article-title":"Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism","volume":"15","author":"Colvin","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib14","doi-asserted-by":"crossref","first-page":"4732","DOI":"10.1182\/blood-2011-07-365338","article-title":"A 2-step approach to myeloablative haploidentical stem cell transplantation: a phase 1\/2 trial performed with optimized T-cell dosing","volume":"118","author":"Grosso","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.07.006_bib15","first-page":"1","article-title":"The role of cytokines in graft-versus-host reactions and disease","volume":"10","author":"Jadus","year":"1992","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib16","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/sj.bmt.1703015","article-title":"Engraftment syndrome following hematopoietic stem cell transplantation","volume":"27","author":"Spitzer","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib17","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J Interferon Cytokine Res"},{"key":"10.1016\/j.exphem.2015.07.006_bib18","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1210\/jc.2002-020980","article-title":"Expression of macrophage inflammatory protein-1beta in human endometrium: its role in endometrial recruitment of natural killer cells","volume":"88","author":"Kitaya","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.exphem.2015.07.006_bib19","first-page":"199","article-title":"Intratumoral expression of MIP-1beta induces antitumor responses in a pre-established tumor model through chemoattracting T cells and NK cells","volume":"1","author":"Luo","year":"2004","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.exphem.2015.07.006_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-2141.2005.05363.x","article-title":"Allogeneic peripheral blood stem cell graft composition affects early T-cell chimaerism and later clinical outcomes after nonmyeloablative conditioning","volume":"128","author":"Panse","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.07.006_bib21","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/bmt.2012.75","article-title":"Extensive chronic GVHD is associated with donor blood CD34+ cell count after G-CSF mobilization in non-myeloablative allogeneic PBSC transplantation","volume":"47","author":"Dh\u00e9din","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.exphem.2015.07.006_bib22","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1038\/sj.leu.2403718","article-title":"High doses of transplanted CD34+ cells are associated with rapid T-cell engraftment and lessened risk of graft rejection, but not more graft-versus-host disease after nonmyeloablative conditioning and unrelated hematopoietic cell transplantation","volume":"19","author":"Baron","year":"2005","journal-title":"Leukemia"},{"key":"10.1016\/j.exphem.2015.07.006_bib23","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1182\/blood-2009-03-208355","article-title":"Donor, recipient, and transplant characteristics as risk factors after unrelated donor PBSC transplantation: beneficial effects of higher CD34+ cell dose","volume":"114","author":"Pulsipher","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.07.006_bib24","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pbc.23107","article-title":"The impact of graft composition on clinical outcomes in pediatric patients undergoing unmanipulated HLA-mismatched\/haploidentical hematopoietic stem cell transplantation","volume":"57","author":"Liu","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.exphem.2015.07.006_bib25","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.exphem.2015.07.006_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/j.1365-2036.2006.03001.x","article-title":"Review article: management of hepatic disease following haematopoietic cell transplant","volume":"24","author":"McDonald","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.exphem.2015.07.006_bib27","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1002\/cncr.27761","article-title":"Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in\u00a0vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center","volume":"119","author":"Wang","year":"2013","journal-title":"Cancer"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15005688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15005688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T08:32:32Z","timestamp":1759566752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15005688"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0301472X15005688"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.07.006","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HLA haploidentical peripheral blood stem cell transplantation using reduced dose of posttransplantation cyclophosphamide for poor-prognosis or refractory leukemia and myelodysplastic syndrome","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}